PhytoNexus

PhytoNexus

Department of Pharmacognosy · Herb-Drug Interaction Intelligence Platform · generated 27 Jul 2026 02:00 IST
Myrtaceae · source entry 31

Eucalyptus globulus

Eucalyptus

Tier 2 · Verified 1 curated · 3 predicted 3Major Risk index 57
Interaction profile

01 Identity and provenance

Accepted binomial
Eucalyptus globulus
Common names
Eucalyptus
Family (APG IV)
Myrtaceae
Part used
Leaf
Verification tier
Tier 2 · Verified Clinical columns reviewed and a source is on record.
Reviewer note (2026 audit)
Reference not supplied - claim unverified against primary literature.

02 Constituent chemistry

Chemical classMarker compoundSynthetic analogue in use
Essential oil 1,8-Cineole
Leaf
Eucalyptol

The analogue column is what makes the interaction reasoning tractable: where a constituent has a marketed structural counterpart, the counterpart's interaction profile is the starting hypothesis for the plant.

Looking up structures and physicochemical properties from PubChem…

03 Stated application

Reported activity
Expectorants
Marketed in
Cough syrup ,Lozenges
Reported adverse effects
Nausea

04 Interaction matrix

Source column, verbatim: CNS depressants
Normalised onto 1 canonical drug class below.

Curated from the reviewed source

Drug classSeverityMechanism type ProvenanceExpected effect
Sedatives, hypnotics and benzodiazepines
CNS
3Major PD-additive curated B Excess sedation, psychomotor and driving impairment, falls, respiratory d… why ▾

Predicted from constituent chemistry

These edges are not clinical findings. Each one is a rule inference: a constituent class in this plant is known to act on a target that the drug class also acts on. They are shown because a blank cell reads as “safe”, and for a Tier 1 entry a blank cell only means “not yet looked at”. Treat them as a literature-search agenda, not as a warning.
Drug classSeverityMechanism type ProvenanceExpected effect
Antiepileptics
CNS
3Major PK-CYP induction + PD-antagonistic predicted D Breakthrough seizures, status epilepticus, or additive sedation and ataxi… why ▾
Hepatotoxic drugs
Organ toxicity
3Major Organ-toxicity additive predicted D Transaminase elevation, cholestasis, sinusoidal obstruction syndrome, acu… why ▾
Topical antiseptics, keratolytics and irritants
Dermatology
3Major PD-additive local predicted D Contact dermatitis, chemical burn, photoirritation, unexpected systemic a… why ▾

05 Hazard register

The audit recorded no hazard beyond the interaction profile. The controlled-vocabulary field reads not assessed, which means the assessment has not been done rather than that it came back clear.

06 Confusable material

No same-genus or shared-common-name entry in the corpus.

07 Mechanism map

Chemistry sorts to the left, pharmacology to the right. Dashed edges are predicted. Drag nodes, scroll to zoom, export at 3× for a figure.

species
chemical class
marker compound
drug class
expected effect
hazard

08 Open literature

Abstract-scoped query built from this binomial, its common names and its marker compounds, run live against Europe PMC, PubMed and OpenAlex, then ranked locally against an evidence hierarchy.

Checking openFDA spontaneous reports…

09 Isomechanistic neighbours

Species whose interaction profile overlaps this one, ranked by shared severity weight rather than by count — a shared contraindication counts for more than a shared minor signal. Practical use: these are the plants you should not stack with this one, because the mechanisms summate.

SpeciesFamilyShared classes WeightJaccard
Achillea millefolium
Yarrow
Asteraceae 4 0.33
Acorus calamus
Vacha
Acoraceae 4 0.57
Melaleuca alternifolia
Tea Tree
Myrtaceae 3 0.60
Amomum subulatum
Black Cardamom
Zingiberaceae 3 0.60
Salvia rosmarinus
Rosemary
Lamiaceae 3 0.60
Salvia officinalis
Sage
Lamiaceae 3 0.60

10 References and notes

No citation is on record for this entry. That is itself the finding: the audit flagged it, and it is why the entry does not carry an A evidence grade.

Curator notes

No notes yet.

Sign in to add notes and save monographs.